Association Between Post-covid Infection Status and Perioperative Morbidity: A Ambispective Cohort Study

January 10, 2024 updated by: Peking Union Medical College Hospital

With the knowledge of currently transmitted omicron variant being less virulent, over 90 percent of the Chinese population is fully vaccinated, and the Chinese health workers have sufficient experience treating the illness. China 's epidemic prevention and control has entered a new stage to restore the normal functioning of society and basic medical services, On Dec, 7, China released a circular on further optimizing its COVID-19 response, announcing 10 new prevention and control measures.This has marked the watershed for sharply increased number of elective surgical patients diagnosed with COVID-19 during preoperativley, fully recovered or during recovery.

Beijing faced a wave of omicron infection starting that would result in of a wide range of population infections. At which time there is limited evidence regarding the optimal timing of surgery following SARS-CoV-2 infection especially for omiron among Chinsese patients .This study intends to explore the relationship between the incidence of postoperative complications after elective surgery and COVID-19 infection in Peking Union Medical College Hospital, and provide data support for the policy formulation of elective surgical timing for patients after COVID-19 infection.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China
        • Peking Union Medical College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

For the part of retrospective study，the investigators intend to include patients who had pre-operative SARS-CoV-2 infection diagnosis and received inpatient surgical intervention at Peking Union Medical College Hospital from December 1, 2022 to January 8, 2023.

For the part of prospective study，the investigators intend to include patients who will receive inpatient surgical intervention with pre-operative SARS-CoV-2 infection diagnosis at Peking Union Medical College Hospital from January 9, 2023 to February 28, 2023.

Description

Inclusion Criteria:

1. All patients having pre-operative SARS-CoV-2 infection diagnosis Dec 1st 2022 to Feb 28th 2023.

[The COVID-19 diagnosis is based on either (a) a positive RT-PCR nasopharyngeal swab, (b) positive antigen rest before surgery, or (c) clinical diagnosis made before surgery].

Exclusion Criteria:

  1. Patients diagnosed with SARS-CoV-2 infection on the day of surgery or during postoperative days.
  2. Day surgery or outpatient surgery.
  3. Patients unwilling to participate or provide COVID-19-related information.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
0-1 week group
Patients who have been infected with Covid-19 with 0-1 week post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
1-2 weeks group
Patients who have been infected with Covid-19 with 1-2 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
2-3 weeks group
Patients who have been infected with Covid-19 with 2-3 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
3-4 weeks group
Patients who have been infected with Covid-19 with 3-4 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
4-5 weeks group
Patients who have been infected with Covid-19 with 4-5 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
5-6 weeks group
Patients who have been infected with Covid-19 with 5-6 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital
over 6 weeks group
Patients who have been infected with Covid-19 with over 6 weeks post-COVID interval before surgery.
Procedure: Receiving inpatient surgical intervention
Receiving inpatient surgical intervention in Peking Union Medical College Hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative complications
Time Frame: During the procedure
The composite primary outcome included pulmonary complications (pneumonia, acute respiratory distress syndrome, or acute respiratory failure, reintubation, unplanned use or prolongation of postoperative mechanical ventilation), cardiovascular complications (deep vein thrombosis, pulmonary embolism, myocardial infarction, newly onset arrhythmia, ischemic stroke, and acute kidney injury), and infectious complications other than pulmonary infection (urinary tract infection, surgical site infection, and sepsis).
During the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of intensive care unit stay
Time Frame: Immediately after leaving intensive care unit
Calculate the number of days the patient stays in the intensive care unit after surgery.
Immediately after leaving intensive care unit

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readmission rate during 30 days after surgery
Time Frame: 30 days after operation
Readmission due to surgery complications during 30 days after operation
30 days after operation
Length of hospital stay
Time Frame: Immediately after discharge
Calculate the number of days the patient stays in the hospital.
Immediately after discharge
Postoperative mechanical ventilation time
Time Frame: During the procedure
Length of mechanical ventilation time after surgery
During the procedure
Intraoperative respiratory complication
Time Frame: During the surgery
Intraoperative respiratory complication: a composite of intraoperative bronchospasm, poor oxygenation, and reintubation.
During the surgery
the WHODisability Assessment Schedule (WHODAS 2.0)
Time Frame: 6 months after operation
  • Step 1-Summing of recoded item scores within each domain.
  • Step 2-Summing of all six domain scores.
  • Step 3-Converting the summary score into a metric ranging from 0 to 100 (where 0=no disability; 100=full disability).
6 months after operation
Brief Pain Inventory (BPI)
Time Frame: 6 months after operation
Brief Pain Inventory used to assess the intensity of pain
6 months after operation
Mortality after operation
Time Frame: 1 month, 3 months, 6 months, 12 months after operation
Mortality after operation in 1 month, 3 months, 6 months, 12 months
1 month, 3 months, 6 months, 12 months after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Peking Union Medical College Hospital

Investigators

  • Study Chair: Shen Le, PhD, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

March 31, 2023

Study Completion (Actual)

January 9, 2024

Study Registration Dates

First Submitted

January 18, 2023

First Submitted That Met QC Criteria

January 18, 2023

First Posted (Actual)

January 19, 2023

Study Record Updates

Last Update Posted (Actual)

January 12, 2024

Last Update Submitted That Met QC Criteria

January 10, 2024

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K23C0257

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Receiving inpatient surgical intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe